Subnavigation

• Initiative for vaccine research
• Vaccine research and development
• Implementation research
• Advisory committees
• Links
• About

WHO meeting on development and evaluation of influenza pandemic vaccines, 2-3 November 2005

Development and evaluation of pandemic vaccines in preclinical and clinical trials - inactivated vaccines

Sanofi Pasteur, USA H5N1 vaccine

• Sanofi Pasteur, USA H5N1 vaccine: Development and preclinical evaluation - James Matthews
  pdf, 84kb
• Sanofi Pasteur, USA H5N1 vaccine: clinical trials - John Treanor
  pdf, 68kb
• Sanofi Pasteur, USA H5N1 vaccine: clinical trials - Wendy Keitel
  pdf, 283kb

Sanofi Pasteur, Europe H5N1 vaccine

• Development, preclinical and clinical trials - Catherine Gerdil-Lacroix
  pdf, 190kb

H5N1 vaccine in Japan

• Development and preclinical evaluation - Yoichiro Kino
  pdf, 1.23Mb
• Clinical evaluation - Masato Tashiro
  pdf, 50kb

H5N1 vaccine in China

• Development and preclinical trials - Jiansan Zhang
  pdf, 604kb

CSL Pharmaceuticals H5N1 vaccine

• Development and evaluation - David Ryan
  pdf, 76kb

Baxter H5N1 vaccine

• Development and evaluation - Otfried Kistner
  pdf, 561kb

H5N1 vaccine in Hungary

• Development and evaluation - Ildico Visontai
  pdf, 985kb

GlaxoSmithKline Biologicals H2N2 and H9N2 vaccines

• Development, preclinical and clinical trials - Norbert Hehme
  pdf, 3.70Mb

Berna Biotech H9N2 vaccine

• Development and evaluation - Reinhard Glück
  pdf, 299kb

Chiron H9N2 vaccine

• Development and clinical trials - Robert Atmar
  pdf, 41kb